Empagliflozin 10 MG trials for Heart failure
All Empagliflozin 10 MG trials · All Heart failure trials
8
Recruiting trials
Phase breakdown
Phase 2 1Phase 3 4Phase 4 4
Recruiting trials studying Empagliflozin 10 MG for Heart failure
- A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
- Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
- Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
- Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
- Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
- Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
- SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
- The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Common questions
How many trials study Empagliflozin 10 MG for Heart failure?
8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.